Report for Vivek Kumar(33Y/M)

Tests asked Wellness 360 With Vitamins, Pot

Test date 02 Jan 2025 Report status Complete Report

Name : VIVEK KUMAR(33Y/M) ADDRESS :
Ref. By : SELF FLAT NO:133 BLOCK:A3 HIMSAGAR APARTMENT
POCKET 4 PH 2 GREATER NOIDA LOCALITY:
KNOWLEDGE PARK 1 LANDMARK: CITY:
GREATER NOIDA

Report Availability Summary

Full Report Available
Note : This is summary page. Please refer to the table below for the details

Test Report Status

POTASSIUM Available

WELLNESS 360 WITH VITAMINS Available

25-OH VITAMIN D (TOTAL) Available

CARDIAC RISK MARKERS Available

CHLORIDE Available

COMPLETE URINE ANALYSIS Available

FASTING BLOOD SUGAR(GLUCOSE) Available

HbA1c Available

HEMOGRAM - 6 PART (DIFF) Available

IRON Available

KIDPRO Available

LIPID PROFILE Available

LIVER FUNCTION TESTS Available

SODIUM Available

TOTAL IRON BINDING CAPACITY (TIBC) Available

TOTAL THYROXINE (T4) Available

TOTAL TRIIODOTHYRONINE (T3) Available

TSH - ULTRASENSITIVE Available

UNSAT.IRON-BINDING CAPACITY(UIBC) Available

Note : Underlined values are Critical Values, Clinician's attention required. Clinically Tested by : Thyrocare Technologies Ltd.
Name : VIVEK KUMAR(33Y/M) ADDRESS :
Ref. By : SELF FLAT NO:133 BLOCK:A3 HIMSAGAR APARTMENT
POCKET 4 PH 2 GREATER NOIDA LOCALITY:
KNOWLEDGE PARK 1 LANDMARK: CITY:
GREATER NOIDA

Report Availability Summary

Full Report Available
Note : This is summary page. Please refer to the table below for the details

Test Report Status

VITAMIN B-12 Available

Note : Underlined values are Critical Values, Clinician's attention required. Clinically Tested by : Thyrocare Technologies Ltd.
 NAME : VIVEK KUMAR(33Y/M) HOME COLLECTION :
REF. BY : SELF FLAT NO:133 BLOCK:A3 HIMSAGAR APARTMENT
POCKET 4 PH 2 GREATER NOIDA LOCALITY:
TEST ASKED : POTASSIUM,WELLNESS 360 WITH VITAMINS KNOWLEDGE PARK 1 LANDMARK: CITY: GREATER
NOIDA

TEST NAME TECHNOLOGY VALUE UNITS

HbA1c - (HPLC)

H.P.L.C 5.5 %

Bio. Ref. Interval. :

Bio. Ref. Interval.: As per ADA Guidelines Guidance For Known Diabetics

Below 5.7% : Normal Below 6.5% : Good Control

5.7% - 6.4% : Prediabetic 6.5% - 7% : Fair Control
>=6.5% : Diabetic 7.0% - 8% : Unsatisfactory Control
>8% : Poor Control
Method : Fully Automated H.P.L.C method

AVERAGE BLOOD GLUCOSE (ABG) CALCULATED 111 mg/dL

Bio. Ref. Interval. :

90 - 120 mg/dl : Good Control
121 - 150 mg/dl : Fair Control
151 - 180 mg/dl : Unsatisfactory Control
> 180 mg/dl : Poor Control
Method : Derived from HBA1c values

Please correlate with clinical conditions.

Sample Collected on (SCT) : 02 Jan 2025 09:38

Sample Received on (SRT) : 02 Jan 2025 14:03
Report Released on (RRT) : 02 Jan 2025 15:32

Sample Type : EDTA Whole Blood

Labcode : 0201073606/DG871 Dr Eesha Gupta MD(Path)
Barcode : DD155037
Page : 1 of 16
Note:- Underlined values are Critical Values, Clinician's attention required. Clinically Tested by :Thyrocare Technologies Ltd - (NABL accredited)
 NAME : VIVEK KUMAR(33Y/M) HOME COLLECTION :
REF. BY : SELF FLAT NO:133 BLOCK:A3 HIMSAGAR APARTMENT
POCKET 4 PH 2 GREATER NOIDA LOCALITY:
TEST ASKED : POTASSIUM,WELLNESS 360 WITH VITAMINS
KNOWLEDGE PARK 1 LANDMARK: CITY:
GREATER NOIDA

TEST NAME METHODOLOGY VALUE UNITS Bio. Ref. Interval.

HEMOGLOBIN SLS-Hemoglobin Method 14 g/dL 13.0-17.0
Hematocrit (PCV) CPH Detection 41 % 40.0-50.0
Total RBC HF & EI 5.04 X 10^6/µL 4.5-5.5
Mean Corpuscular Volume (MCV) Calculated 81.3 fL 83.0-101.0
Mean Corpuscular Hemoglobin (MCH) Calculated 27.8 pq 27.0-32.0
Mean Corp.Hemo. Conc (MCHC) Calculated 34.1 g/dL 31.5-34.5
Red Cell Distribution Width - SD (RDW-SD) Calculated 39.6 fL 39-46
Red Cell Distribution Width (RDW - CV) Calculated 13.6 % 11.6-14
RED CELL DISTRIBUTION WIDTH INDEX (RDWI) Calculated 219.4 - *Refer Note below
MENTZER INDEX Calculated 16.1 - *Refer Note below
TOTAL LEUCOCYTE COUNT (WBC) HF & FC 8.58 X 10³ / µL 4.0 - 10.0
DIFFERENTIAL LEUCOCYTE COUNT
Neutrophils Percentage Flow Cytometry 58.2 % 40-80
Lymphocytes Percentage Flow Cytometry 31.9 % 20-40
Monocytes Percentage Flow Cytometry 4 % 2-10
Eosinophils Percentage Flow Cytometry 5.1 % 1-6
Basophils Percentage Flow Cytometry 0.5 % 0-2
Immature Granulocyte Percentage (IG%) Flow Cytometry 0.3 % 0-0.5
Nucleated Red Blood Cells % Flow Cytometry 0.01 % 0.0-5.0
ABSOLUTE LEUCOCYTE COUNT
Neutrophils - Absolute Count Calculated 4.99 X 10³ / µL 2.0-7.0
Lymphocytes - Absolute Count Calculated 2.74 X 10³ / µL 1.0-3.0
Monocytes - Absolute Count Calculated 0.34 X 10³ / µL 0.2 - 1.0
Basophils - Absolute Count Calculated 0.04 X 10³ / µL 0.02 - 0.1
Eosinophils - Absolute Count Calculated 0.44 X 10³ / µL 0.02 - 0.5
Immature Granulocytes (IG) Calculated 0.03 X 10³ / µL 0-0.3
Nucleated Red Blood Cells Calculated 0.01 X 10³ / µL 0.0-0.5
PLATELET COUNT HF & EI 151 X 10³ / µL 150-410
Remarks : Alert!!! Predominantly normocytic normochromic with ovalocytes. Platelets:Appear adequate in smear.

*Note - Mentzer index (MI), RDW-CV and RDWI are hematological indices to differentiate between Iron Deficiency Anemia (IDA) and Beta
Thalassemia Trait (BTT). MI >13, RDWI >220 and RDW-CV >14 more likely to be IDA. MI <13, RDWI <220, and RDW-CV <14 more likely
to be BTT. Suggested Clinical correlation. BTT to be confirmed with HB electrophoresis if clinically indicated.
Method : Fully automated bidirectional analyser (6 Part Differential SYSMEX XN-1000)
(Reference : *FC- flowcytometry, *HF- hydrodynamic focussing, *EI- Electric Impedence, *Hb- hemoglobin, *CPH- Cumulative pulse height)

Sample Collected on (SCT) : 02 Jan 2025 09:38

Sample Received on (SRT) : 02 Jan 2025 14:03
Report Released on (RRT) : 02 Jan 2025 15:32
Sample Type : EDTA Whole Blood
Labcode : 0201073606/DG871 Dr Eesha Gupta MD(Path)
Barcode : DD155037 Page : 2 of 16

Note:- Underlined values are Critical Values, Clinician's attention required. Clinically Tested by :Thyrocare Technologies Ltd - (NABL accredited)
 NAME : VIVEK KUMAR(33Y/M) HOME COLLECTION :
REF. BY : SELF FLAT NO:133 BLOCK:A3 HIMSAGAR APARTMENT
POCKET 4 PH 2 GREATER NOIDA LOCALITY:
TEST ASKED : POTASSIUM,WELLNESS 360 WITH VITAMINS KNOWLEDGE PARK 1 LANDMARK: CITY: GREATER
NOIDA

TEST NAME TECHNOLOGY VALUE UNITS

25-OH VITAMIN D (TOTAL) E.C.L.I.A 24 ng/mL

Bio. Ref. Interval. :

Deficiency : <=20 ng/ml || Insufficiency : 21-29 ng/ml

Sufficiency : >= 30 ng/ml || Toxicity : >100 ng/ml

Clinical Significance:
Vitamin D is a fat soluble vitamin that has been known to help the body absorb and retain calcium and phosphorous; both are critical for
building bone health.
Decrease in vitamin D total levels indicate inadequate exposure of sunlight, dietary deficiency, nephrotic syndrome.
Increase in vitamin D total levels indicate Vitamin D intoxication.

Specifications: Precision: Intra assay (%CV):9.20%, Inter assay (%CV):8.50%

Kit Validation Reference : Holick M. Vtamin D the underappreciated D-Lightful hormone that is important for Skeletal
and cellular health Curr Opin Endocrinol Diabetes 2002:9(1)87-98.
Method : Fully Automated Electrochemiluminescence Compititive Immunoassay

VITAMIN B-12 E.C.L.I.A 188 pg/mL

Bio. Ref. Interval. :

Normal: 197-771 pg/ml

Clinical significance :
Vitamin B12 or cyanocobalamin, is a complex corrinoid compound found exclusively from animal dietary sources, such as meat, eggs and
milk. It is critical in normal DNA synthesis, which in turn affects erythrocyte maturation and in the formation of myelin sheath. Vitamin-B12
is used to find out neurological abnormalities and impaired DNA synthesis associated with macrocytic anemias. For diagnostic purpose,
results should always be assessed in conjunction with the patients medical history, clinical examination and other findings.

Specifications: Intra assay (%CV):2.6%, Inter assay (%CV):2.3 %

Kit Validation Reference : Thomas L.Clinical laborator Diagnostics : Use and Assessment of Clinical laboratory Results 1st Edition,TH
Books-Verl-Ges,1998:424-431
Method : Fully Automated Electrochemiluminescence Compititive Immunoassay

Please correlate with clinical conditions.

Sample Collected on (SCT) : 02 Jan 2025 09:38

Sample Received on (SRT) : 02 Jan 2025 14:05
Report Released on (RRT) : 02 Jan 2025 18:27

Sample Type : SERUM

Labcode : 0201073723/DG871 Dr Eesha Gupta MD(Path)
Barcode : CY304338
Page : 3 of 16
Note:- Underlined values are Critical Values, Clinician's attention required. Clinically Tested by :Thyrocare Technologies Ltd
 NAME : VIVEK KUMAR(33Y/M) HOME COLLECTION :
REF. BY : SELF FLAT NO:133 BLOCK:A3 HIMSAGAR APARTMENT
POCKET 4 PH 2 GREATER NOIDA LOCALITY:
TEST ASKED : POTASSIUM,WELLNESS 360 WITH VITAMINS KNOWLEDGE PARK 1 LANDMARK: CITY: GREATER
NOIDA

TEST NAME TECHNOLOGY VALUE UNITS

APOLIPOPROTEIN - A1 (APO-A1) IMMUNOTURBIDIMETRY 114 mg/dL

Bio. Ref. Interval. :

Male : 86 - 152
Female : 94 - 162
Method : FULLY AUTOMATED RATE IMMUNOTURBIDIMETRY – BECKMAN COULTER

APOLIPOPROTEIN - B (APO-B) IMMUNOTURBIDIMETRY 88 mg/dL

Bio. Ref. Interval. :

Male : 56 - 145
Female : 53 - 138
Method : FULLY AUTOMATED RATE IMMUNOTURBIDIMETRY – BECKMAN COULTER

APO B / APO A1 RATIO (APO B/A1) CALCULATED 0.8 Ratio

Bio. Ref. Interval. :

Male : 0.40 - 1.26

Female : 0.38 - 1.14

Clinical Significance :

• Apolipoprotein B is a more potent and independent predictor of Coronary artery disease (CAD) than LDL Cholesterol.
• Apolipoprotein A1 is one of the apoproteins of HDL and is inversely related to risk of CAD.
• The Apolipoprotein studies help in monitoring risk of restenosis in patients with myocardial infarction, Coronary bypass surgery etc.
• An increased ratio of Apo B to A1 beyond the defined normal range is indicative of CAD risk.
• All results have to be interpreted in Conjunction with clinical history and other findings.
Method : Derived from serum Apo A1 and Apo B values

Please correlate with clinical conditions.

Sample Collected on (SCT) : 02 Jan 2025 09:38

Sample Received on (SRT) : 02 Jan 2025 14:05
Report Released on (RRT) : 02 Jan 2025 18:27

Sample Type : SERUM

Labcode : 0201073723/DG871 Dr Eesha Gupta MD(Path)
Barcode : CY304338
Page : 4 of 16
Note:- Underlined values are Critical Values, Clinician's attention required. Clinically Tested by :Thyrocare Technologies Ltd - (NABL accredited)
 NAME : VIVEK KUMAR(33Y/M) HOME COLLECTION :

REF. BY : SELF FLAT NO:133 BLOCK:A3 HIMSAGAR APARTMENT

POCKET 4 PH 2 GREATER NOIDA LOCALITY:
TEST ASKED : POTASSIUM,WELLNESS 360 WITH VITAMINS KNOWLEDGE PARK 1 LANDMARK: CITY: GREATER
NOIDA
TEST NAME TECHNOLOGY VALUE UNITS
HIGH SENSITIVITY C-REACTIVE PROTEIN (HS-CRP) IMMUNOTURBIDIMETRY 4.2 mg/L
Bio. Ref. Interval. :-

< 1.00 - Low Risk

1.00 - 3.00 - Average Risk
>3.00 - 10.00 - High Risk
> 10.00 - Possibly due to Non-Cardiac Inflammation

Disclaimer: Persistent unexplained elevation of HSCRP >10 should be evaluated for non-cardiovascular etiologies such as
infection , active arthritis or concurrent illness.

Clinical significance:
High sensitivity C- reactive Protein ( HSCRP) can be used as an independent risk marker for the identification of Individuals at risk
for future cardiovascular Disease. A coronary artery disease risk assessment should be based on the average of two hs-CRP
tests, ideally taken two weeks apart.

Kit Validation Reference:

1.Clinical management of laboratory date in medical practice 2003-3004, 207(2003).
2.Tietz : Textbook of Clinical Chemistry and Molecular diagnostics :Second edition :Chapter 47:Page no.1507- 1508.

Please correlate with clinical conditions.

Method:- FULLY AUTOMATED LATEX AGGLUTINATION – BECKMAN COULTER

Sample Collected on (SCT) : 02 Jan 2025 09:38

Sample Received on (SRT) : 02 Jan 2025 14:05
Report Released on (RRT) : 02 Jan 2025 18:27

Sample Type : SERUM

Labcode : 0201073723/DG871 Dr Eesha Gupta MD(Path)

Barcode : CY304338 Page : 5 of 16

Note:- Underlined values are Critical Values, Clinician's attention required. Clinically Tested by :Thyrocare Technologies Ltd - (NABL accredited)
 NAME : VIVEK KUMAR(33Y/M) HOME COLLECTION :

REF. BY : SELF FLAT NO:133 BLOCK:A3 HIMSAGAR APARTMENT

POCKET 4 PH 2 GREATER NOIDA LOCALITY:
TEST ASKED : POTASSIUM,WELLNESS 360 WITH VITAMINS KNOWLEDGE PARK 1 LANDMARK: CITY: GREATER
NOIDA
TEST NAME TECHNOLOGY VALUE UNITS
LIPOPROTEIN (A) [LP(A)] IMMUNOTURBIDIMETRY 7.4 mg/dL
Bio. Ref. Interval. :-

Adults : < 30.0 mg/dl

Clinical Significance:
Determination of LPA may be useful to guide management of individuals with a family history of CHD or with existing disease. The
levels of LPA in the blood depends on genetic factors; The range of variation in a population is relatively large and hence for
diagnostic purpose, results should always be assessed in conjunction with the patient’s medical history, clinical examination and
other findings.

Specifications:
Precision %CV :- Intra assay %CV- 4.55% , Inter assay %CV-0.86 %

Kit Validation Reference:

Tietz NW,Clinical Guide to Laboratory Tests Philadelphia WB. Saunders 1995 : 442-444

Please correlate with clinical conditions.

Method:- LATEX ENHANCED IMMUNOTURBIDIMETRY

Sample Collected on (SCT) : 02 Jan 2025 09:38

Sample Received on (SRT) : 02 Jan 2025 14:05
Report Released on (RRT) : 02 Jan 2025 18:27

Sample Type : SERUM

Labcode : 0201073723/DG871 Dr Eesha Gupta MD(Path)

Barcode : CY304338 Page : 6 of 16

Note:- Underlined values are Critical Values, Clinician's attention required. Clinically Tested by :Thyrocare Technologies Ltd - (NABL accredited)
 NAME : VIVEK KUMAR(33Y/M) HOME COLLECTION :
REF. BY : SELF FLAT NO:133 BLOCK:A3 HIMSAGAR APARTMENT
POCKET 4 PH 2 GREATER NOIDA LOCALITY:
TEST ASKED : POTASSIUM,WELLNESS 360 WITH VITAMINS KNOWLEDGE PARK 1 LANDMARK: CITY: GREATER
NOIDA

TEST NAME TECHNOLOGY VALUE UNITS

IRON PHOTOMETRY 61.11 µg/dL

Bio. Ref. Interval. :

Male : 65 - 175
Female : 50 - 170
Method : Ferrozine method without deproteinization

TOTAL IRON BINDING CAPACITY (TIBC) PHOTOMETRY 400.17 µg/dL

Bio. Ref. Interval. :

Male: 225 - 535 µg/dl Female: 215 - 535 µg/dl

Method : Spectrophotometric Assay

% TRANSFERRIN SATURATION CALCULATED 15.27 %

Bio. Ref. Interval. :

13 - 45
Method : Derived from IRON and TIBC values

UNSAT.IRON-BINDING CAPACITY(UIBC) PHOTOMETRY 339.06 µg/dL

Bio. Ref. Interval. :

162 - 368
Method : SPECTROPHOTOMETRIC ASSAY

Please correlate with clinical conditions.

Sample Collected on (SCT) : 02 Jan 2025 09:38

Sample Received on (SRT) : 02 Jan 2025 14:05
Report Released on (RRT) : 02 Jan 2025 18:27

Sample Type : SERUM

Labcode : 0201073723/DG871 Dr Eesha Gupta MD(Path)
Barcode : CY304338
Page : 7 of 16
Note:- Underlined values are Critical Values, Clinician's attention required. Clinically Tested by :Thyrocare Technologies Ltd
 NAME : VIVEK KUMAR(33Y/M) HOME COLLECTION :
REF. BY FLAT NO:133 BLOCK:A3 HIMSAGAR APARTMENT POCKET
: SELF
4 PH 2 GREATER NOIDA LOCALITY: KNOWLEDGE PARK 1
TEST ASKED : POTASSIUM,WELLNESS 360 WITH VITAMINS LANDMARK: CITY: GREATER NOIDA

TEST NAME TECHNOLOGY VALUE UNITS Bio. Ref. Interval.

TOTAL CHOLESTEROL PHOTOMETRY 154 mg/dL < 200
HDL CHOLESTEROL - DIRECT PHOTOMETRY 35 mg/dL 40-60
LDL CHOLESTEROL - DIRECT PHOTOMETRY 102 mg/dL < 100
TRIGLYCERIDES PHOTOMETRY 159 mg/dL < 150
TC/ HDL CHOLESTEROL RATIO CALCULATED 4.4 Ratio 3-5
TRIG / HDL RATIO CALCULATED 4.51 Ratio < 3.12
LDL / HDL RATIO CALCULATED 2.9 Ratio 1.5-3.5
HDL / LDL RATIO CALCULATED 0.35 Ratio > 0.40
NON-HDL CHOLESTEROL CALCULATED 119.24 mg/dL < 160
VLDL CHOLESTEROL CALCULATED 31.78 mg/dL 5 - 40
Please correlate with clinical conditions.

Method :

CHOL - Cholesterol Oxidase, Esterase, Peroxidase

HCHO - Direct Enzymatic Colorimetric
LDL - Direct Measure
TRIG - Enzymatic, End Point
TC/H - Derived from serum Cholesterol and Hdl values
TRI/H - Derived from TRIG and HDL Values
LDL/ - Derived from serum HDL and LDL Values
HD/LD - Derived from HDL and LDL values.
NHDL - Derived from serum Cholesterol and HDL values
VLDL - Derived from serum Triglyceride values

*REFERENCE RANGES AS PER NCEP ATP III GUIDELINES:

TOTAL CHOLESTEROL LDL (mg/dl) TRIGLYCERIDES

(mg/dl) HDL (mg/dl) (mg/dl)

DESIRABLE <200 LOW OPTIMAL <100 NORMAL <150

<40

BORDERLINE HIGH 200-239 HIGH >60 NEAR OPTIMAL 100-129 BORDERLINE HIGH 150-199

HIGH >240 BORDERLINE HIGH 130-159 HIGH 200-499

HIGH 160-189 VERY HIGH >500

VERY HIGH >190

Alert !!! 10-12 hours fasting is mandatory for lipid parameters. If not, values might fluctuate.

Sample Collected on (SCT) : 02 Jan 2025 09:38

Sample Received on (SRT) : 02 Jan 2025 14:05
Report Released on (RRT) : 02 Jan 2025 18:27

Sample Type : SERUM

Labcode : 0201073723/DG871 Dr Eesha Gupta MD(Path)

Barcode : CY304338
Page : 8 of 16
Note:- Underlined values are Critical Values, Clinician's attention required. Clinically Tested by :Thyrocare Technologies Ltd - (NABL accredited)
 NAME : VIVEK KUMAR(33Y/M) HOME COLLECTION :
REF. BY FLAT NO:133 BLOCK:A3 HIMSAGAR APARTMENT POCKET
: SELF
4 PH 2 GREATER NOIDA LOCALITY: KNOWLEDGE PARK 1
TEST ASKED : POTASSIUM,WELLNESS 360 WITH VITAMINS LANDMARK: CITY: GREATER NOIDA

TEST NAME TECHNOLOGY VALUE UNITS Bio. Ref. Interval.

ALKALINE PHOSPHATASE PHOTOMETRY 103.98 U/L 45-129
BILIRUBIN - TOTAL PHOTOMETRY 0.53 mg/dL 0.3-1.2
BILIRUBIN -DIRECT PHOTOMETRY 0.09 mg/dL < 0.3
BILIRUBIN (INDIRECT) CALCULATED 0.44 mg/dL 0-0.9
GAMMA GLUTAMYL TRANSFERASE (GGT) PHOTOMETRY 39.11 U/L < 55
ASPARTATE AMINOTRANSFERASE (SGOT ) PHOTOMETRY 40.18 U/L < 35
ALANINE TRANSAMINASE (SGPT) PHOTOMETRY 75.95 U/L < 45
SGOT / SGPT RATIO CALCULATED 0.53 Ratio <2
PROTEIN - TOTAL PHOTOMETRY 6.93 gm/dL 5.7-8.2
ALBUMIN - SERUM PHOTOMETRY 4.14 gm/dL 3.2-4.8
SERUM GLOBULIN CALCULATED 2.79 gm/dL 2.5-3.4
SERUM ALB/GLOBULIN RATIO CALCULATED 1.48 Ratio 0.9 - 2
Please correlate with clinical conditions.

Method :

ALKP - Modified IFCC method

BILT - Vanadate Oxidation
BILD - Vanadate Oxidation
BILI - Derived from serum Total and Direct Bilirubin values
GGT - Modified IFCC method
SGOT - IFCC* Without Pyridoxal Phosphate Activation
SGPT - IFCC* Without Pyridoxal Phosphate Activation
OT/PT - Derived from SGOT and SGPT values.
PROT - Biuret Method
SALB - Albumin Bcg¹method (Colorimetric Assay Endpoint)
SEGB - DERIVED FROM SERUM ALBUMIN AND PROTEIN VALUES
A/GR - Derived from serum Albumin and Protein values

Sample Collected on (SCT) : 02 Jan 2025 09:38

Sample Received on (SRT) : 02 Jan 2025 14:05
Report Released on (RRT) : 02 Jan 2025 18:27

Sample Type : SERUM

Labcode : 0201073723/DG871 Dr Eesha Gupta MD(Path)

Barcode : CY304338
Page : 9 of 16
Note:- Underlined values are Critical Values, Clinician's attention required. Clinically Tested by :Thyrocare Technologies Ltd - (NABL accredited)
 NAME : VIVEK KUMAR(33Y/M) HOME COLLECTION :
REF. BY : SELF FLAT NO:133 BLOCK:A3 HIMSAGAR APARTMENT
POCKET 4 PH 2 GREATER NOIDA LOCALITY:
TEST ASKED : POTASSIUM,WELLNESS 360 WITH VITAMINS KNOWLEDGE PARK 1 LANDMARK: CITY: GREATER
NOIDA

TEST NAME TECHNOLOGY VALUE UNITS

CHLORIDE I.S.E - INDIRECT 105.4 mmol/L

Bio. Ref. Interval. :

ADULTS: 98-107 MMOL/L

Clinical Significance :
An increased level of blood chloride (called hyperchloremia) usually indicates dehydration, but can also occur with other problems that
cause high blood sodium, such as Cushing syndrome or kidney disease. Hyperchloremia also occurs when too much base is lost from the
body (producing metabolic acidosis) or when a person hyperventilates (causing respiratory alkalosis). A decreased level of blood chloride
(called hypochloremia) occurs with any disorder that causes low blood sodium. Hypochloremia also occurs with congestive heart failure,
prolonged vomiting or gastric suction, Addison disease, emphysema or other chronic lung diseases (causing respiratory acidosis), and
with loss of acid from the body (called metabolic alkalosis).
Method : ION SELECTIVE ELECTRODE - INDIRECT

SODIUM I.S.E - INDIRECT 141 mmol/L

Bio. Ref. Interval. :

ADULTS: 136-145 MMOL/L

Method : ION SELECTIVE ELECTRODE - INDIRECT

POTASSIUM I.S.E - INDIRECT 4.86 mmol/L

Bio. Ref. Interval. :

ADULTS: 3.5-5.1 MMOL/L

Clinical Significance :
An abnormal increase in potassium (hyperkalemia)can profoundly affect the nervous system and increase the chance of irregular
heartbeats (arrhythmias), which ,when extreme ,can be fatal. The assay could be affected mildly and may result in anomalous values if
serum samples have heterophilic antibodies, hemolyzed , icteric or lipemic. The concentration of Potassium in a given specimen may vary
due to differences in assay methods, calibration and reagent specificity.
Method : ION SELECTIVE ELECTRODE - INDIRECT

Please correlate with clinical conditions.

Sample Collected on (SCT) : 02 Jan 2025 09:38

Sample Received on (SRT) : 02 Jan 2025 14:05
Report Released on (RRT) : 02 Jan 2025 18:27

Sample Type : SERUM

Labcode : 0201073723/DG871 Dr Eesha Gupta MD(Path)
Barcode : CY304338
Page : 10 of 16
Note:- Underlined values are Critical Values, Clinician's attention required. Clinically Tested by :Thyrocare Technologies Ltd - (NABL accredited)
 NAME : VIVEK KUMAR(33Y/M) HOME COLLECTION :
REF. BY FLAT NO:133 BLOCK:A3 HIMSAGAR APARTMENT POCKET
: SELF
4 PH 2 GREATER NOIDA LOCALITY: KNOWLEDGE PARK 1
TEST ASKED : POTASSIUM,WELLNESS 360 WITH VITAMINS LANDMARK: CITY: GREATER NOIDA

TEST NAME TECHNOLOGY VALUE UNITS Bio. Ref. Interval.

BLOOD UREA NITROGEN (BUN) PHOTOMETRY 14.1 mg/dL 7.94 - 20.07
CREATININE - SERUM PHOTOMETRY 0.6 mg/dL 0.72-1.18
BUN / SR.CREATININE RATIO CALCULATED 23.5 Ratio 9:1-23:1
UREA (CALCULATED) CALCULATED 30.17 mg/dL Adult : 17-43
UREA / SR.CREATININE RATIO CALCULATED 50.29 Ratio < 52
CALCIUM PHOTOMETRY 9.28 mg/dL 8.8-10.6
URIC ACID PHOTOMETRY 6.76 mg/dL 4.2 - 7.3
Please correlate with clinical conditions.

Method :

BUN - Kinetic UV Assay.

SCRE - Creatinine Enzymatic Method
B/CR - Derived from serum Bun and Creatinine values
UREAC - Derived from BUN Value.
UR/CR - Derived from UREA and Sr.Creatinine values.
CALC - Arsenazo III Method, End Point.
URIC - Uricase / Peroxidase Method

Sample Collected on (SCT) : 02 Jan 2025 09:38

Sample Received on (SRT) : 02 Jan 2025 14:05
Report Released on (RRT) : 02 Jan 2025 18:27

Sample Type : SERUM

Labcode : 0201073723/DG871 Dr Eesha Gupta MD(Path)

Barcode : CY304338
Page : 11 of 16
Note:- Underlined values are Critical Values, Clinician's attention required. Clinically Tested by :Thyrocare Technologies Ltd - (NABL accredited)
 NAME : VIVEK KUMAR(33Y/M) HOME COLLECTION :
FLAT NO:133 BLOCK:A3 HIMSAGAR APARTMENT POCKET
REF. BY : SELF
4 PH 2 GREATER NOIDA LOCALITY: KNOWLEDGE PARK 1
TEST ASKED : POTASSIUM,WELLNESS 360 WITH VITAMINS LANDMARK: CITY: GREATER NOIDA

TEST NAME TECHNOLOGY VALUE UNITS Bio. Ref. Interval.

TOTAL TRIIODOTHYRONINE (T3) E.C.L.I.A 143 ng/dL 80-200

TOTAL THYROXINE (T4) E.C.L.I.A 11.6 µg/dL 4.8-12.7
TSH - ULTRASENSITIVE E.C.L.I.A 4.62 µIU/mL 0.54-5.30

Comments : SUGGESTING THYRONORMALCY

The Biological Reference Ranges is specific to the age group. Kindly correlate clinically.
Method :
T3 - Fully Automated Electrochemiluminescence Compititive Immunoassay
T4 - Fully Automated Electrochemiluminescence Compititive Immunoassay
USTSH - Fully Automated Electrochemiluminescence Sandwich Immunoassay

Disclaimer :

Results should always be interpreted using the reference range provided by the laboratory that performed the test.
Different laboratories do tests using different technologies, methods and using different reagents which may cause difference
In reference ranges and hence it is recommended to interpret result with assay specific reference ranges provided in the reports.
To diagnose and monitor therapy doses, it is recommended to get tested every time at the same Laboratory.

Sample Collected on (SCT) : 02 Jan 2025 09:38

Sample Received on (SRT) : 02 Jan 2025 14:05
Report Released on (RRT) : 02 Jan 2025 18:27
Sample Type : SERUM
Labcode : 0201073723/DG871 Dr Eesha Gupta MD(Path)
Barcode : CY304338 Page : 12 of 16

Note:- Underlined values are Critical Values, Clinician's attention required. Clinically Tested by :Thyrocare Technologies Ltd
 NAME : VIVEK KUMAR(33Y/M) HOME COLLECTION :

REF. BY : SELF FLAT NO:133 BLOCK:A3 HIMSAGAR APARTMENT

POCKET 4 PH 2 GREATER NOIDA LOCALITY:
TEST ASKED : POTASSIUM,WELLNESS 360 WITH VITAMINS KNOWLEDGE PARK 1 LANDMARK: CITY: GREATER
NOIDA
TEST NAME TECHNOLOGY VALUE UNITS
EST. GLOMERULAR FILTRATION RATE (eGFR) CALCULATED 132 mL/min/1.73 m2
Bio. Ref. Interval. :-

> = 90 : Normal
60 - 89 : Mild Decrease
45 - 59 : Mild to Moderate Decrease
30 - 44 : Moderate to Severe Decrease
15 - 29 : Severe Decrease

Clinical Significance

The normal serum creatinine reference interval does not necessarily reflect a normal GFR for a patient. Because mild and
moderate kidney injury is poorly inferred from serum creatinine alone. Thus, it is recommended for clinical laboratories to routinely
estimate glomerular filtration rate (eGFR), a “gold standard” measurement for assessment of renal function, and report the value
when serum creatinine is measured for patients 18 and older, when appropriate and feasible. It cannot be measured easily in
clinical practice, instead, GFR is estimated from equations using serum creatinine, age, race and sex. This provides easy to
interpret information for the doctor and patient on the degree of renal impairment since it approximately equates to the
percentage of kidney function remaining. Application of CKD-EPI equation together with the other diagnostic tools in renal
medicine will further improve the detection and management of patients with CKD.

Reference

Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, 3rd, Feldman HI, et al. A new equation to estimate glomerular filtration
rate. Ann Intern Med. 2009;150(9):604-12.

Please correlate with clinical conditions.

Method:- CKD-EPI Creatinine Equation

Sample Collected on (SCT) : 02 Jan 2025 09:38

Sample Received on (SRT) : 02 Jan 2025 14:05
Report Released on (RRT) : 02 Jan 2025 18:27

Sample Type : SERUM

Labcode : 0201073723/DG871 Dr Eesha Gupta MD(Path)

Barcode : CY304338 Page : 13 of 16

Note:- Underlined values are Critical Values, Clinician's attention required. Clinically Tested by :Thyrocare Technologies Ltd - (NABL accredited)
 NAME : VIVEK KUMAR(33Y/M) HOME COLLECTION :
REF. BY : SELF FLAT NO:133 BLOCK:A3 HIMSAGAR APARTMENT
TEST ASKED : POTASSIUM,WELLNESS 360 WITH VITAMINS POCKET 4 PH 2 GREATER NOIDA LOCALITY:
KNOWLEDGE PARK 1 LANDMARK: CITY: GREATER
NOIDA

TEST NAME METHODOLOGY VALUE UNITS Bio. Ref. Interval.

Complete Urinogram
Physical Examination
VOLUME Visual Determination 3 mL -
COLOUR Visual Determination PALE YELLOW - Pale Yellow
APPEARANCE Visual Determination CLEAR - Clear
SPECIFIC GRAVITY pKa change 1.02 - 1.003-1.030
PH pH indicator 5.5 - 5-8
Chemical Examination
URINARY PROTEIN PEI ABSENT mg/dL Absent
URINARY GLUCOSE GOD-POD ABSENT mg/dL Absent
URINE KETONE Nitroprusside ABSENT mg/dL Absent
URINARY BILIRUBIN Diazo coupling ABSENT mg/dL Absent
UROBILINOGEN Diazo coupling Normal mg/dL <=0.2
BILE SALT Hays sulphur ABSENT - Absent
BILE PIGMENT Ehrlich reaction ABSENT - Absent
URINE BLOOD Peroxidase reaction ABSENT - Absent
NITRITE Diazo coupling ABSENT - Absent
LEUCOCYTE ESTERASE Esterase reaction ABSENT - Absent
Microscopic Examination
MUCUS Microscopy ABSENT - Absent
RED BLOOD CELLS Microscopy ABSENT cells/HPF 0-5
URINARY LEUCOCYTES (PUS CELLS) Microscopy ABSENT cells/HPF 0-5
EPITHELIAL CELLS Microscopy ABSENT cells/HPF 0-5
CASTS Microscopy ABSENT - Absent
CRYSTALS Microscopy CALCIUM OXALATE - Absent
CRYSTALS
BACTERIA Microscopy ABSENT - Absent
YEAST Microscopy ABSENT - Absent
PARASITE Microscopy ABSENT - Absent

(Reference : *PEI - Protein error of indicator, *GOD-POD - Glucose oxidase-peroxidase)

Sample Collected on (SCT) : 02 Jan 2025 09:38

Sample Received on (SRT) : 02 Jan 2025 14:46
Report Released on (RRT) : 02 Jan 2025 17:03
Sample Type : URINE
Labcode : 0201076508/DG871 Dr Eesha Gupta MD(Path)

Barcode : CW831816 Page : 14 of 16

Note:- Underlined values are Critical Values, Clinician's attention required. Clinically Tested by :Thyrocare Technologies Ltd - (NABL accredited)
 NAME : VIVEK KUMAR(33Y/M) HOME COLLECTION :

REF. BY : SELF FLAT NO:133 BLOCK:A3 HIMSAGAR APARTMENT

POCKET 4 PH 2 GREATER NOIDA LOCALITY:
TEST ASKED : POTASSIUM,WELLNESS 360 WITH VITAMINS KNOWLEDGE PARK 1 LANDMARK: CITY: GREATER
NOIDA
TEST NAME TECHNOLOGY VALUE UNITS
FASTING BLOOD SUGAR(GLUCOSE) PHOTOMETRY 90.36 mg/dL

Bio. Ref. Interval. :-

As per ADA Guideline: Fasting Plasma Glucose (FPG)

Normal 70 to 100 mg/dl

Prediabetes 100 mg/dl to 125 mg/dl

Diabetes 126 mg/dl or higher

Note :
The assay could be affected mildly and may result in anomalous values if serum samples have heterophilic antibodies, hemolyzed ,
icteric or lipemic. The concentration of Glucose in a given specimen may vary due to differences in assay methods, calibration and
reagent specificity. For diagnostic purposes results should always be assessed in conjunction with patients medical history, clinical
findings and other findings.

Please correlate with clinical conditions.

Method:- GOD-PAP METHOD

~~ End of report ~~

Sample Collected on (SCT) : 02 Jan 2025 09:38

Sample Received on (SRT) : 02 Jan 2025 14:22
Report Released on (RRT) : 02 Jan 2025 15:01

Sample Type : FLUORIDE PLASMA

Labcode : 0201075060/DG871 Dr Eesha Gupta MD(Path)

Barcode : CX265297 Page : 15 of 16

Note:- Underlined values are Critical Values, Clinician's attention required. Clinically Tested by :Thyrocare Technologies Ltd - (NABL accredited)
 CONDITIONS OF REPORTING

v The reported results are for information and interpretation of the referring doctor only.
v It is presumed that the tests performed on the specimen belong to the patient; named or identified.
v Results of tests may vary from laboratory to laboratory and also in some parameters from time to time for the
same patient.
v Should the results indicate an unexpected abnormality, the same should be reconfirmed.
v Only such medical professionals who understand reporting units, reference ranges and limitations of technologies
should interpret results.
v This report is not valid for medico-legal purpose.
v Docon Technologies Private Limited,Thyrocare Technologies Limited and its employees/representatives do not
assume any liability,responsibility for any loss or damage that may be incurred by any person as a result of
presuming the meaning or contents of the report.

EXPLANATIONS

v Name - The name is as declared by the client and recorded by the personnel who collected the specimen.
v Ref.By - The name of the doctor who has recommended testing as declared by the client.
v Labcode - This is the accession number in our laboratory and it helps us in archiving and retrieving the data.
v Barcode - This is the specimen identity number and it states that the results are for the specimen bearing the
barcode (irrespective of the name).
v SCT - Specimen Collection Time - The time when specimen was collected as declared by the client.
v SRT - Specimen Receiving Time - This time when the specimen reached our laboratory.
v RRT - Report Releasing Time - The time when our pathologist has released the values for Reporting.
v Reference Range - Means the range of values in which 95% of the normal population would fall.

SUGGESTIONS

v Values out of reference range requires reconfirmation before starting any medical treatment.
v Retesting is needed if you suspect any quality shortcomings.
v For suggestions, complaints or feedback, write to us at [email protected] or call us on 7022000900.

Page : 16 of 16